☆ 4.8 Letter

Consequences of Identifying XIAP Deficiency in an Adult Patient With Inflammatory Bowel Disease

GASTROENTEROLOGY (2018)

Journal

GASTROENTEROLOGY

Volume 155, Issue 1, Pages 231-234

Publisher

W B SAUNDERS CO-ELSEVIER INC

DOI: 10.1053/j.gastro.2018.03.069

Keywords

-

Categories

Gastroenterology & Hepatology

Funding

Eli Lilly
NIHR Biomedical Research Centre Oxford
Leona M. and Harry B. Helmsley Charitable Trust
Crohn's & Colitis Foundation of America
NIHR Senior followship
Wellcome Trust [098051]

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Review Immunology

Primary Immunodeficiencies Associated With Early-Onset Inflammatory Bowel Disease in Southeast and East Asia

Yoji Sasahara, Takashi Uchida, Tasuku Suzuki, Daiki Abukawa

Summary: This review investigates the prevalence, clinical manifestation, genetic profile, and treatment of patients with early-onset inflammatory bowel disease (IBD) in Southeast and East Asia, specifically looking at the association with primary immunodeficiency diseases (PIDs). The study found that the prevalence of PID associated with IBD was higher in Southeast and East Asia compared to Western countries, and patients with bloody stools as an early symptom were more likely to have monogenic diseases. Comprehensive molecular diagnosis has been widely applied in this region to screen for PID-associated IBD patients. These findings contribute to the understanding of monogenic PIDs in early-onset IBD patients and their clinical manifestations and genetic profiles compared to Western countries.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Review Gastroenterology & Hepatology

Identifying, Understanding, and Managing Fecal Urgency in Inflammatory Bowel Diseases

Benedicte Caron, Subrata Ghosh, Silvio Danese, Laurent Peyrin-Biroulet

Summary: Fecal urgency is a common and distressing symptom experienced by patients with inflammatory bowel disease, but there is a lack of standardized definition, pathophysiology, and therapeutic management. Medications such as loperamide, tricyclic antidepressants, and biofeedback therapy may be necessary when nonpharmacologic measures fail. However, medical management of fecal urgency is challenging due to limited data from randomized clinical trials.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2023)

Add to Collection

Review Immunology

Adjunctive therapeutic effects of micronutrient supplementation in inflammatory bowel disease

Yanrui Wu, Chuan Liu, Weiguo Dong

Summary: Growing evidence suggests that micronutrient status may affect the course of inflammatory bowel disease (IBD), but deficiencies are often overlooked during treatment. Studies have focused on vitamin D and iron supplementation, but research on other vitamins and minerals is still limited. This review provides an overview of the therapeutic effects of micronutrient supplementation in IBD, aiming to draw attention to monitoring and supplementation in IBD patients and provide perspectives for future research.

FRONTIERS IN IMMUNOLOGY (2023)

Add to Collection

Article Gastroenterology & Hepatology

Creation of an Inflammatory Bowel Disease Referral Pathway for Identifying Patients Who Would Benefit From Inflammatory Bowel Disease Specialist Consultation

Frank Scott, Orna Ehrlich, Dallas Wood, Catherine Viator, Carrie Rains, Lisa DiMartino, Jill McArdle, Gabrielle Adams, Lara Barkoff, Jennifer Caudle, Jianfeng Cheng, Jami Kinnucan, Kimberly Persley, Jennifer Sariego, Samir Shah, Caren Heller, David T. Rubin

Summary: This study developed a care pathway for patients with inflammatory bowel disease (IBD) to prompt appropriate consultation with IBD specialists. The pathway included major and minor criteria identified through a literature review and expert panel discussions. Implementation barriers and facilitators were also assessed. The care pathway provides key criteria for triaging IBD patients and future research is needed to validate its effectiveness.

INFLAMMATORY BOWEL DISEASES (2023)

Add to Collection

Review Medicine, General & Internal

Metabolomics as a Promising Resource Identifying Potential Biomarkers for Inflammatory Bowel Disease

Cristina Bauset, Laura Gisbert-Ferrandiz, Jesus Cosin-Roger

Summary: IBD is a chronic gastrointestinal disorder characterized by disruption of epithelial barrier function and immune response, lacking biomarkers for early diagnosis. Metabolomics may reveal promising metabolites to understand pathology and identify therapeutic targets.

JOURNAL OF CLINICAL MEDICINE (2021)

Add to Collection

Article Gastroenterology & Hepatology

Holistic healthcare in inflammatory bowel disease: time for patient-centric approaches?

Padhmanand Sudhakar, Judith Wellens, Bram Verstockt, Marc Ferrante, Joao Sabino, Severine Vermeire

Summary: Inflammatory bowel disease (IBD) is a global disease that affects the gastrointestinal tract and also has an impact on the mental and emotional well-being of patients. Despite medical advancements, only a third of diagnosed patients achieve short to medium-term remission. Therefore, some patients might resort to complementary and alternative approaches to manage their symptoms. This study reviews the efficacy of these approaches and proposes a patient-centric clinical care model and recommendations.

GUT (2023)

Add to Collection

Review Nutrition & Dietetics

Prevalence of Zinc Deficiency in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis

Roberta Zupo, Annamaria Sila, Fabio Castellana, Roberto Bringiotti, Margherita Curlo, Giovanni De Pergola, Sara De Nucci, Gianluigi Giannelli, Mauro Mastronardi, Rodolfo Sardone

Summary: Inflammatory bowel disease (IBD) patients, particularly those with Crohn's disease (CD), are at high risk of zinc deficiency. Proper management of micronutrient deficiencies, including monitoring zinc levels in serum, is crucial for improving the health outcomes of IBD patients.

NUTRIENTS (2022)

Add to Collection

Article Medicine, General & Internal

Anemia and Iron Deficiency in Outpatients with Inflammatory Bowel Disease: Ubiquitous Yet Suboptimally Managed

Roberta Loveikyte, Menno Boer, Catharina N. van der Meulen, Rinze W. F. ter Steege, Greetje Tack, Johan Kuyvenhoven, Bindia Jharap, My K. Vu, Lauran Vogelaar, Rachel L. West, Sander van der Marel, Tessa E. H. Romkens, Zlatan Mujagic, Frank Hoentjen, Adriaan A. van Bodegraven, Fiona D. M. van Schaik, Annemarie C. de Vries, Gerard Dijkstra, Andrea E. Van der Meulen-de Jong

Summary: This study assessed the prevalence of iron deficiency (ID) and anemia in Dutch outpatients with Inflammatory Bowel Disease (IBD) and compared the routine ID(A) management among medical professionals to the treatment guidelines. The findings showed that one in five IBD patients suffered from anemia, and most medical professionals treated anemic ID with standard doses of oral or intravenous iron while non-anemic ID was often overlooked.

JOURNAL OF CLINICAL MEDICINE (2022)

Add to Collection

Article Gastroenterology & Hepatology

Prevalence, Pathogenesis and Management of Anemia in Inflammatory Bowel Disease: An IG-IBD Multicenter, Prospective, and Observational Study

Gaetano Bergamaschi, Fabiana Castiglione, Renata D'Inca, Marco Astegiano, Walter Fries, Monica Milla, Carolina Ciacci, Fernando Rizzello, Simone Saibeni, Rachele Ciccocioppo, Ambrogio Orlando, Fabrizio Bossa, Mariabeatrice Principi, Piero Vernia, Chiara Ricci, Maria L. Scribano, Giorgia Bodini, Dario Mazzucco, Gabrio Bassotti, Gabriele Riegler, Andrea Buda, Matteo Neri, Flavio Caprioli, Fabio Monica, Aldo Manca, Erica Villa, Gionata Fiorino, Michele Comberlato, Nicola Aronico, Cristina Della Corte, Roberta Caccaro, Paolo Gionchetti, Paolo Giuffrida, Paola Iovino, Marco Lenti, Caterina Mengoli, Lucienne Pellegrini, Alberto Pieraccini, Davide Ribaldone, Anna Testa, Cristina Ubezio, Anna Viola, Maurizio Vecchi, Catherine Klersy, Antonio Di Sabatino

Summary: The prevalence of anemia in Italian IBD patients is lower than previously reported, with the majority being caused by iron deficiency and leading to fatigue and decreased quality of life. However, a large proportion of patients with iron and/or vitamin deficiencies remain untreated.

INFLAMMATORY BOWEL DISEASES (2023)

Add to Collection

Review Gastroenterology & Hepatology

Safety of Immunizations for the Adult Patient With Inflammatory Bowel Disease-A Systematic Review and Meta-analysis

Athanasios Desalermos, Michael Pimienta, Markos Kalligeros, Fadi Shehadeh, Leonidas Diamantopoulos, George Karamanolis, Freddy Caldera, Francis A. Farraye

Summary: Patients with inflammatory bowel disease (IBD) have low vaccination rates. Fear of adverse reactions (AEs) negatively affects vaccination efforts. Our study shows that AEs following vaccination in IBD patients are mainly local or mild systemic reactions, which are similar to those expected in the general population.

INFLAMMATORY BOWEL DISEASES (2022)

Add to Collection

Article Multidisciplinary Sciences

Identifying high-impact variants and genes in exomes of Ashkenazi Jewish inflammatory bowel disease patients

Yiming Wu, Kyle Gettler, Meltem Ece Kars, Mamta Giri, Dalin Li, Cigdem Sevim Bayrak, Peng Zhang, Aayushee Jain, Patrick Maffucci, Ksenija Sabic, Tielman Van Vleck, Girish Nadkarni, Lee A. Denson, Harry Ostrer, Adam P. Levine, Elena R. Schiff, Anthony W. Segal, Subra Kugathasan, Peter D. Stenson, David N. Cooper, L. Philip Schumm, Scott Snapper, Mark J. Daly, Talin Haritunians, Richard H. Duerr, Mark S. Silverberg, John D. Rioux, Steven R. Brant, Dermot P. B. McGovern, Judy H. Cho, Yuval Itan

Summary: In this study, novel IBD-associated variants and genes are identified by sequencing the genomes of 4453 Ashkenazi Jewish IBD cases and controls. The physiological relevance of these genes to IBD is demonstrated through biological pathway analyses and RNA sequencing. The study also reveals the genetic overlap between adult IBD in Ashkenazi Jews and early-onset IBD, as well as the pleiotropic effects of IBD genes on other immune responses. Lastly, it is shown that polygenic risk score analyses based on high impact variants have high predictive power for IBD susceptibility.

NATURE COMMUNICATIONS (2023)

Add to Collection

Article Allergy

Hematopoietic Cell Transplantation Rescues Inflammatory Bowel Disease and Dysbiosis of Gut Microbiota in XIAP Deficiency

Shintaro Ono, Kozue Takeshita, Yuko Kiridoshi, Motohiro Kato, Takahiro Kamiya, Akihiro Hoshino, Masakatsu Yanagimachi, Katsuhiro Arai, Ichiro Takeuchi, Nariaki Toita, Toshihiko Imamura, Yoji Sasahara, Junichi Sugita, Kazuko Hamamoto, Masanobu Takeuchi, Shoji Saito, Masaei Onuma, Hiroshi Tsujimoto, Masahiro Yasui, Takashi Taga, Yuki Arakawa, Yuichi Mitani, Nobuyuki Yamamoto, Kohsuke Imai, Wataru Suda, Masahira Hattori, Osamu Ohara, Tomohiro Morio, Kenya Honda, Hirokazu Kanegane

Summary: The study showed a favorable outcome of HCT for XIAP deficiency, rescuing gut inflammation and dysbiosis in these patients.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2021)

Add to Collection

Article Gastroenterology & Hepatology

Gut microbiota in mucosa and feces of newly diagnosed, treatment-naive adult inflammatory bowel disease and irritable bowel syndrome patients

Hana Cipcic Paljetak, Anja Baresic, Marina Panek, Mihaela Peric, Mario Matijasic, Ivana Lojkic, Ana Barisic, Darija Vranesic Bender, Dina Ljubas Kelecic, Marko Brinar, Mirjana Kalauz, Marija Milicevic, Dora Grgic, Niksa Turk, Irena Karas, Silvija Cukovic-Cavka, Zeljko Krznaric, Donatella Verbanac

Summary: This study compares the differences in gut microbiota between newly diagnosed, treatment-naive adult inflammatory bowel disease (IBD) patients (CD and UC) with irritable bowel syndrome (IBS) patients and healthy individuals. The results show that changes in gut microbiota are detectable at the onset of disease and may play a significant role in the development of IBD.

GUT MICROBES (2022)

Add to Collection

Article Gastroenterology & Hepatology

Prevalence and factors associated with vitamin C deficiency in inflammatory bowel disease

Benjamin Langan Gordon, Jonathan S. Galati, Stevie Yang, Randy S. Longman, Dana Lukin, Ellen J. Scherl, Robert Battat

Summary: Vitamin C deficiency is common in patients with inflammatory bowel disease, especially in those with elevated inflammatory markers and penetrating disease.

WORLD JOURNAL OF GASTROENTEROLOGY (2022)

Add to Collection

Article Cell Biology

Characterizing the pre-clinical phase of inflammatory bowel disease

Marie Vibeke Vestergaard, Kristine H. Allin, Gry J. Poulsen, James C. Lee, Tine Jess

Summary: In this study, we provide a comprehensive characterization of the hematological and biochemical changes that occur in the pre-clinical phase of inflammatory bowel disease (IBD), revealing significant changes up to several years before diagnosis, which could facilitate earlier intervention.

CELL REPORTS MEDICINE (2023)

Add to Collection

Article Gastroenterology & Hepatology

Multicentre derivation and validation of a colitis-associated colorectal cancer risk prediction web tool

Kit Curtius, Misha Kabir, Ibrahim Al Bakir, Chang Ho Ryan Choi, Juanda L. Hartono, Michael Johnson, James E. East, James O. Lindsay, Roser Vega, Siwan Thomas-Gibson, Janindra Warusavitarne, Ana Wilson, Trevor A. Graham, Ailsa Hart

Summary: This study identified that patients with large, unresected, multifocal LGD and recent moderate/severe inflammation are at highest risk of developing advanced neoplasia. Personalised risk prediction provided via the Ulcerative Colitis-Cancer Risk Estimator can support treatment decision-making.

GUT (2022)

Add to Collection

Article Biochemistry & Molecular Biology

The P5-type ATPase ATP13A1 modulates major histocompatibility complex I-related protein 1 (MR1)-mediated antigen presentation

Corinna A. Kulicke, Erica De Zan, Zeynep Hein, Claudia Gonzalez-Lopez, Swapnil Ghanwat, Natacha Veerapen, Gurdyal S. Besra, Paul Klenerman, John C. Christianson, Sebastian Springer, Sebastian M. Nijman, Vincenzo Cerundolo, Mariolina Salio

Summary: The MR1-MAIT cell axis is involved in various diseases, and this study discovered that ATP13A1 in the endoplasmic reticulum is a key factor in MR1 surface expression.

JOURNAL OF BIOLOGICAL CHEMISTRY (2022)

Add to Collection

Article Gastroenterology & Hepatology

A pan-genotype hepatitis C virus viral vector vaccine generates T cells and neutralizing antibodies in mice

Timothy Donnison, Joey McGregor, Senthil Chinnakannan, Claire Hutchings, Rob J. Center, Pantelis Poumbourios, Paul Klenerman, Heidi E. Drummer, Eleanor Barnes

Summary: This study aims to develop a vaccine that can generate both viral-specific B-cell and T-cell responses concurrently to target multiple HCV genotypes.

HEPATOLOGY (2022)

Add to Collection

Article Genetics & Heredity

Genetic associations at regulatory phenotypes improve fine-mapping of causal variants for 12 immune-mediated diseases

Kousik Kundu, Alice L. Mann, Manuel Tardaguila, Stephen Watt, Hannes Ponstingl, Louella Vasquez, Nicholas W. Morrell, Oliver Stegle, Tomi Pastinen, Stephen J. Sawcer, Carl A. Anderson, Klaudia Walter, Nicole Soranzo

Summary: The colocalization of regulatory quantitative trait loci from the BLUEPRINT project with genetic association data aids in the fine-mapping of putative causal variants for 12 immune-mediated diseases.

NATURE GENETICS (2022)

Add to Collection

Review Immunology

MAIT cells in liver inflammation and fibrosis

Hema Mehta, Martin Joseph Lett, Paul Klenerman, Magdalena Filipowicz Sinnreich

Summary: MAIT cells are a unique subset of T lymphocytes abundant in humans, especially in the liver, that bridge innate and adaptive immunity by responding to bacterial metabolites presented by MR1. They possess a wide array of cytokine receptors, enabling them to respond independently of TCR. This distinctive cell type plays a role not only in infection or inflammation, but also in maintaining homeostasis and could have therapeutic implications in liver diseases.

SEMINARS IN IMMUNOPATHOLOGY (2022)

Add to Collection

Correction Immunology

MAIT cells in liver inflammation and fibrosis (vol 44, pg 429, 2022)

Hema Mehta, Martin Joseph Lett, Paul Klenerman, Magdalena Filipowicz Sinnreich

SEMINARS IN IMMUNOPATHOLOGY (2022)

Add to Collection

Article Genetics & Heredity

Large-scale sequencing identifies multiple genes and rare variants associated with Crohn's disease susceptibility

Aleksejs Sazonovs, Christine R. Stevens, Guhan R. Venkataraman, Kai Yuan, Brandon Avila, Maria T. Abreu, Tariq Ahmad, Matthieu Allez, Ashwin N. Ananthakrishnan, Gil Atzmon, Aris Baras, Jeffrey C. Barrett, Nir Barzilai, Laurent Beaugerie, Ashley Beecham, Charles N. Bernstein, Alain Bitton, Bernd Bokemeyer, Andrew Chan, Daniel Chung, Isabelle Cleynen, Jacques Cosnes, David J. Cutler, Allan Daly, Oriana M. Damas, Lisa W. Datta, Noor Dawany, Marcella Devoto, Sheila Dodge, Eva Ellinghaus, Laura Fachal, Martti Farkkila, William Faubion, Manuel Ferreira, Denis Franchimont, Stacey B. Gabriel, Tian Ge, Michel Georges, Kyle Gettler, Mamta Giri, Benjamin Glaser, Siegfried Goerg, Philippe Goyette, Daniel Graham, Eija Hamalainen, Talin Haritunians, Graham A. Heap, Mikko Hiltunen, Marc Hoeppner, Julie E. Horowitz, Peter Irving, Vivek Iyer, Chaim Jalas, Judith Kelsen, Hamed Khalili, Barbara S. Kirschner, Kimmo Kontula, Jukka T. Koskela, Subra Kugathasan, Juozas Kupcinskas, Christopher A. Lamb, Matthias Laudes, Chloe Levesque, Adam P. Levine, James D. Lewis, Claire Liefferinckx, Britt-Sabina Loescher, Edouard Louis, John Mansfield, Sandra May, Jacob L. McCauley, Emebet Mengesha, Myriam Mni, Paul Moayyedi, Christopher J. Moran, Rodney D. Newberry, Sirimon O'Charoen, David T. Okou, Bas Oldenburg, Harry Ostrer, Aarno Palotie, Jean Paquette, Joel Pekow, Inga Peter, Marieke J. Pierik, Cyriel Y. Ponsioen, Nikolas Pontikos, Natalie Prescott, Ann E. Pulver, Souad Rahmouni, Daniel L. Rice, Paivi Saavalainen, Bruce Sands, R. Balfour Sartor, Elena R. Schiff, Stefan Schreiber, L. Philip Schumm, Anthony W. Segal, Philippe Seksik, Rasha Shawky, Shehzad Z. Sheikh, Mark S. Silverberg, Alison Simmons, Jurgita Skeiceviciene, Harry Sokol, Matthew Solomonson, Hari Somineni, Dylan Sun, Stephan Targan, Dan Turner, Holm H. Uhlig, Andrea E. van der Meulen, Severine Vermeire, Sare Verstockt, Michiel D. Voskuil, Harland S. Winter, Justine Young, Richard H. Duerr, Andre Franke, Steven R. Brant, Judy Cho, Rinse K. Weersma, Miles Parkes, Ramnik J. Xavier, Manuel A. Rivas, John D. Rioux, Dermot P. B. McGovern, Hailiang Huang, Carl A. Anderson, Mark J. Daly

Summary: Genome-wide association studies have identified new risk variants and susceptibility genes for Crohn's disease. These studies highlight the crucial role of immune cells and autophagy in the development of Crohn's disease, and also emphasize the importance of mesenchymal cells in intestinal inflammation.

NATURE GENETICS (2022)

Add to Collection

Article Cell Biology

Prostaglandins differentially modulate mucosal-associated invariant T-cell activation and function according to stimulus

Hema Mehta, Irene Tasin, Carl Philipp Hackstein, Christian Willberg, Paul Klenerman

Summary: Mucosal-associated invariant T (MAIT) cells are a type of innate-like T-cell that is conserved in many mammals and abundant in humans. They have a semi-invariant T-cell receptor (TCR) that recognizes riboflavin intermediates associated with microbial metabolism. MAIT cell activation can be triggered by cytokines and is highly sensitive to local soluble mediators. Prostaglandins can potentially modulate the functions of MAIT cells in vivo, with distinct effects on TCR-dependent and TCR-independent pathways of activation.

IMMUNOLOGY AND CELL BIOLOGY (2023)

Add to Collection

Editorial Material Cell Biology

MR1: An unconventional twist in the tail

Prabhjeet Phalora, Paul Klenerman

JOURNAL OF CELL BIOLOGY (2022)

Add to Collection

Review Immunology

MAITs and their mates: Innate-like behaviors in conventional and unconventional T cells

Carl-Philipp Hackstein, Paul Klenerman

Summary: T cells can recognize conventional or unconventional ligands and exhibit innate-like features and independent responses in an antigen-dependent or -independent manner. Unconventional T cells, such as MAIT cells, show innate-like features and respond independently of their T cell receptors (TCRs), while conventional T cells, such as T(MIC) cells, also exhibit innate-like behavior. The abilities to recognize antigens presented by unconventional antigen-presenting molecules or to mount TCR-independent responses create unique niches for these T cells.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2023)

Add to Collection

Article Multidisciplinary Sciences

Long non-coding RNA-derived peptides are immunogenic and drive a potent anti-tumour response

Wojciech Barczak, Simon M. M. Carr, Geng Liu, Shonagh Munro, Annalisa Nicastri, Lian Ni Lee, Claire Hutchings, Nicola Ternette, Paul Klenerman, Alexander Kanapin, Anastasia Samsonova, Nicholas B. B. La Thangue

Summary: PRMT5, an over-expressed protein arginine methyltransferase (PRMT) in various cancers, plays a role in regulating the non-coding genome by affecting long non-coding (lnc) RNA gene expression. Additionally, inhibiting PRMT5 or adjusting E2F1 levels alters the repertoire of lncRNA-derived peptide antigens displayed by tumor cells and lncRNA-derived peptides can induce a potent antigen-specific CD8 T lymphocyte response when used as a cancer vaccine.

NATURE COMMUNICATIONS (2023)

Add to Collection

Article Nutrition & Dietetics

Is Autologous Fecal Microbiota Transfer after Exclusive Enteral Nutrition in Pediatric Crohn's Disease Patients Rational and Feasible? Data from a Feasibility Test

Hannes Hoelz, Jeannine Heetmeyer, Anastasia Tsakmaklis, Andreas Hiergeist, Kolja Siebert, Federica De Zen, Deborah Haecker, Amira Metwaly, Klaus Neuhaus, Andre Gessner, Maria J. G. T. Vehreschild, Dirk Haller, Tobias Schwerd

Summary: Background: Exclusive enteral nutrition (EEN) is effective for pediatric Crohn's disease (CD) but relapse rates are high after return to regular diet. This study explored the use of autologous fecal microbiota transfer (FMT) for maintaining the benefits of EEN. Methods: Fecal material from pediatric CD patients was turned into FMT capsules, with microbial composition analyzed before and after processing. Results: FMT capsules were successfully generated in most deliveries, but there was variability in stool weight and consistency. Microbial composition was not significantly altered by processing, but samples often had low microbial richness and positive results for potential pathogens or drug resistance genes. Conclusions: Autologous capsule-FMT may not be suitable for maintenance therapy in pediatric CD patients due to high pathogen burden, low microbial diversity, and practical limitations of EEN-conditioned fecal material.

NUTRIENTS (2023)

Add to Collection

Review Medicine, General & Internal

The Use of JAK/STAT Inhibitors in Chronic Inflammatory Disorders

Giuseppina Caiazzo, Anna Caiazzo, Maddalena Napolitano, Matteo Megna, Luca Potestio, Luigi Fornaro, Melania Parisi, Maria Antonietta Luciano, Angelo Ruggiero, Anna Testa, Fabiana Castiglione, Cataldo Patruno, Maria Quaranta, Gabriella Fabbrocini

Summary: The JAK/STAT pathway plays a critical role in immune and inflammatory responses, as well as various cellular processes. Its involvement in the pathogeneses of chronic inflammatory conditions like psoriasis, atopic dermatitis, and inflammatory bowel diseases has been extensively studied. However, the exact impact of this pathway on the pathogenesis of inflammatory conditions remains unclear.

JOURNAL OF CLINICAL MEDICINE (2023)

Add to Collection

Article Immunology

Type I interferons drive MAIT cell functions against bacterial pneumonia

Juan Carlos Lopez-Rodriguez, Steven J. Hancock, Kelin Li, Stefania Crotta, Christopher Barrington, Alejandro Suarez-Bonnet, Simon L. Priestnall, Jeffrey Aube, Andreas Wack, Paul Klenerman, Jose A. Bengoechea, Patricia Barral

Summary: Mucosal-associated invariant T (MAIT) cells in the lungs are important for host defense against infections. This study demonstrates that MAIT cell activation during bacterial pneumonia caused by Klebsiella pneumoniae is independent of MR1 and driven by type I interferons (IFNs). Type I IFNs stimulate the activation and effector functions of MAIT cells and play a central role in their response to Klebsiella infection. This finding suggests that targeting type I IFNs could be a strategy to manipulate MAIT cell functions during bacterial infections.

JOURNAL OF EXPERIMENTAL MEDICINE (2023)

Add to Collection

Article Immunology

Single-cell analysis of human MAIT cell transcriptional, functional and clonal diversity

Lucy C. Garner, Ali Amini, Michael E. B. FitzPatrick, Martin J. Lett, Gabriel F. Hess, Magdalena Filipowicz Sinnreich, Nicholas M. Provine, Paul Klenerman

Summary: Garner et al. analyzed the single-cell transcriptome and TCR repertoire of matched blood and liver, and resting and activated, human MAIT cells. They identify donor-specific TCR repertoires shared across tissues and a transcriptome that is largely homogeneous at rest, but highly adaptive to different tissue and stimulation environments.

NATURE IMMUNOLOGY (2023)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.